Anxiety and Depression In Patients With Obstructive Sleep Apnoea Before and After Continuous Positive Airway Pressure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-01

Study Completion Date

2019-10-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Continuous positive airway pressure (CPAP) is the gold-standard treatment for obstructive sleep apnoea (OSA), the most common sleep-disordered breathing in the overall population. CPAP has shown to be effective in reducing apnoea-hypopnoea index (AHI) as well as other OSA polysomnographic outcomes. However, the effectiveness of this device on OSA daily functioning and mood disturbances outcomes still remains unclear. The ADIPOSA study is aimed at determining the effects of three-month CPAP use on anxiety-depression symptoms in patients with OSA. Participants will be adults previously diagnosed with OSA who will be allocated to a CPAP-treatment group. Outcomes will be measured at baseline and intervention end-point (three months) including daytime sleepiness, daily functioning and mood (anxiety and depression symptoms), AHI, other neurophysical and cardiorespiratory polysomnographic outcomes, and body weight. ADIPOSA may serve to establish the effectiveness of CPAP on daytime functioning and mood disturbances commonly found on patients with OSA and, in turn, on other OSA outcomes related to anxiety-depression symptoms.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Interest of Treatment of Obstructive Sleep Apnea Syndrome by Constant CPAP and Auto CPAP

NCT02749812

Obstructive Sleep Apnea Syndromes

COMPLETED NA

Effort-based Decision-making and CPAP Adherence

NCT04557293

Obstructive Sleep Apnea Adherence

RECRUITING NA

Effect of CPAP vs Control on Nocturnal Dipping in Normotensive Patients With Obstructive Sleep Apnea

NCT04938128

Sleep Apnea, Obstructive

WITHDRAWN NA

Effect of Continuous Positive Airway Pressure (CPAP) on Systemic Blood Pressure, Coagulability and Carotid Intima-media Thickness in Patients With Sleep Apnea

NCT00300599

Obstructive Sleep Apnoea

COMPLETED NA

Benefits of Telemedicine in CPAP Treatment

NCT03202602

Obstructive Sleep Apnea

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Uncontrolled before-and-after study

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Continuous Positive Airway Pressure (CPAP) group

Three-month CPAP use

Group Type EXPERIMENTAL

Continuous positive airway pressure (CPAP)

Intervention Type DEVICE

Adults previously diagnosed with obstructive sleep apnoea will receive a three-month CPAP intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Continuous positive airway pressure (CPAP)

Adults previously diagnosed with obstructive sleep apnoea will receive a three-month CPAP intervention

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Previous clinical diagnosis of mild/moderate/severe OSA (AHI \> 5) by a healthcare professional
* Use of CPAP
* Motivation to participate in the study
* Willing to provide informed consent

Exclusion Criteria

* Presence of any other primary sleep disorder
* Presence of any mental disorder (including depression, anxiety, and addiction to alcohol or other substances)
* Presence of any other severe organic disease, except for those comorbid to OSA

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No